WEKO3
アイテム
RADIATION THERAPY FOR STAGE ⅢB UTERINE CERVICAL CANCER AT OUR INSTITUTION : TREATMENT OUTCOMES AND PROGNOSTIC FACTORS
https://doi.org/10.20569/00005086
https://doi.org/10.20569/00005086bd8815e8-15cc-48e3-906f-33ddb1259465
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
akitai46_3_4(9) (788.1 kB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2020-07-20 | |||||
| タイトル | ||||||
| タイトル | RADIATION THERAPY FOR STAGE ⅢB UTERINE CERVICAL CANCER AT OUR INSTITUTION : TREATMENT OUTCOMES AND PROGNOSTIC FACTORS | |||||
| 言語 | en | |||||
| 言語 | ||||||
| 言語 | jpn | |||||
| 主題 | ||||||
| 言語 | en | |||||
| 主題Scheme | Other | |||||
| 主題 | uterine cervical cancer | |||||
| 主題 | ||||||
| 言語 | en | |||||
| 主題Scheme | Other | |||||
| 主題 | radiotherapy | |||||
| 主題 | ||||||
| 言語 | en | |||||
| 主題Scheme | Other | |||||
| 主題 | brachytherapy | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| ID登録 | ||||||
| ID登録 | 10.20569/00005086 | |||||
| ID登録タイプ | JaLC | |||||
| アクセス権 | ||||||
| アクセス権 | open access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||
| 作成者 |
Takagi, Noriko
× Takagi, Noriko× Anbai, Akira× Wada, Yuki× Kumagai, Satoshi× Okuyama, Eriko× Hatakeyama, Kento× Sato, Naoki× Hashimoto, Manabu |
|||||
| 内容記述 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Purpose We examined the treatment outcomes,prognostic factors,and toxicities after radiotherapy for stage IIIB uterine cervical cancer. Methods and Materials We studied patients with stage IIIB uterine cervical cancer who were both diagnosed and treated with combined external beam radiotherapy(EBRT) and intracavitary brachytherapy(ICBT). We retrospectively analyzed the clinical characteristics(age,primary tumor size,lymph node metastasis,and chemotherapy),5-year overall survival(OS) rate,progressionfree survival(PFS) rate,and late toxicities over grade 3. Results A total of 25 patients were enrolled in this study.Overall 23 and 2 patients showed complete and partial response,respectively.The objective response was 100%.The 5-year OS and PFS were 73.4% (95% confidence interval [CI] 55.1-91.6%) and 69% (95% CI 49.5-88.0%), respectively.Primary tumor size ≥40 mm was a prognostic factor for poor OS and PFS (HR : 5.088, p=0.024 and HR : 5.088, p=0.033, respectively). Five patients(20%) developed late toxicities over grade 3 with related radiotherapy. Conclusions Local tumor control,OS,PFS,and late toxicity rate in this study were similar to those in previous reports. A bulky tumor was identified as a prognostic factor. |
|||||
| 言語 | en | |||||
| 出版タイプ | ||||||
| 出版タイプ | VoR | |||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
| 書誌情報 |
ja : 秋田医学 en : Akita journal of medicine 巻 46, 号 3/4, p. 79-90, 発行日 2020-03-30 |
|||||
| 収録物識別子 | ||||||
| 収録物識別子タイプ | PISSN | |||||
| 収録物識別子 | 0386-6106 | |||||
| 収録物識別子 | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AN00009294 | |||||
| 出版者 | ||||||
| 出版者 | 秋田医学会 | |||||
| 言語 | ja | |||||
